ESMO-Virtual-Preceptorship-Head-and-Neck-Cancer-2021-1000x250

Start date: 24 Sep 2021
End date: 25 Sep 2021
Location: Virtual, GMT +8

Learning objectives

To understand epidemiology, aetiology and molecular nasopharyngeal cancer and squamous cell carcinoma of head and neck (HNSCC)
To understand multidisciplinary management and treatment of head and neck cancer
To learn about advances in the treatment and novel targets in head and neck cancer
To learn about management and treatment of salivary gland cancer

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Anthony T.C. Chan, Hong Kong
Jean-Pascal Machiels, Belgium

Learning objectives

Accreditation

Co-Chairs

Supported by

You may also be interested in...